A Randomized Phase 3 Study Evaluating the Efficacy and Safety of Alogliptin in Pediatric Participants with Type 2 Diabetes Mellitus
Diabetes Therapy（2025）
Key words
Alogliptin,Antihyperglycemic agents,Dipeptidyl peptidase-4 inhibitor,DPP-4 inhibitor,Pediatric type 2 diabetes mellitus,Youth-onset type 2 diabetes mellitus
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined